Xiulan Zhao

Dr. Xiulan Zhao


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2022 in Chemosphere
Verified
Journal Article
Closed access
SSShan Shan
Shan Shan
YZYifan Zhang
Yifan Zhang
HZHuiwen Zhao
Huiwen Zhao
TZTao Zeng
Tao Zeng
XZXiulan Zhao
Xiulan Zhao

1 January 2016 in Neuroscience Letters
Verified
Journal Article
Closed access
ZWZengjin Wang
Zengjin Wang
XWXiaomin Wei
Xiaomin Wei
JYJunlin Yang
Junlin Yang
JSJinning Suo
Jinning Suo
JCJingyi Chen
Jingyi Chen
XZXiulan Zhao
Xiulan Zhao

6 February 2018 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
LXLin Xu
Lin Xu
WZWenchao Zhang
Wenchao Zhang
XLXianchen Liu
Xianchen Liu
CZCuili Zhang
Cuili Zhang
PWPin Wang
Pin Wang
XZXiulan Zhao
Xiulan Zhao
Background: Environmental exposure to toxic metals has been postulated to play a role in the pathophysiological processes of Alzheimer’s disease (AD). However, the circulatory levels of toxic metals in AD patients are not consistent in previous studies. Objective: To systematically assess levels of toxic metals (aluminum, mercury, cadmium, lead) in the circulation (blood, serum/plasma) of AD patients and controls. Methods: PubMed, Web of Science, Science Direct, Cochrane Library, and the China National Knowledge Infrastructure (CNKI) were systematically searched to identify studies published up to January 1, 2017. Meta-analyses were performed using random-effects models and the pooled standardized mean difference (SMD) were reported with 95% confidence intervals (CI). Results: We identified 17, 7, 8, and 10 studies for aluminum, mercury, cadmium, and lead, respectively. Meta-analyses showed significantly elevated circulatory levels of aluminum (SMD = 1.08, 95% CI: 0.66, 1.50), mercury (SMD = 0.55, 95% CI, 0.15, 0.95), and cadmium (SMD = 0.62, 95% CI: 0.12, 1.11), whereas lower levels of lead (SMD = –0.23, 95% CI: –0.38, –0.07) in AD patients than in controls. Publication bias was only observed for aluminum studies, but the “trim and fill” analysis showed that the publication bias did not alter the direction of the effect. Sensitivity analyses showed no studies from the pooled analysis changed the results. Conclusion: Compared to controls, circulatory levels of aluminum, mercury, and cadmium are significantly higher but the levels of lead were reduced in AD patients. These findings suggest that elevated aluminum, mercury, and cadmium in the circulation, especially in serum may play a role in the progression of AD.

1 October 2021 in Toxicology Letters
Verified
Journal Article
Closed access
XQXiaofei Qiu
Xiaofei Qiu
QWQinghui Wang
Qinghui Wang
LHLiyan Hou
Liyan Hou
CZCuili Zhang
Cuili Zhang
QWQingshan Wang
Qingshan Wang
XZXiulan Zhao
Xiulan Zhao

8 January 2021 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
MSMingxue Song
Mingxue Song
XZXiulan Zhao
Xiulan Zhao
FSFuyong Song
Fuyong Song

23 March 2023 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
LZLiwen Zhang
Liwen Zhang
DCDong Cheng
Dong Cheng
JZJing Zhang
Jing Zhang
HTHui Tang
Hui Tang
FLFenghua Li
Fenghua Li
JZJun Zhou
Jun Zhou